Calcium for Kidney Stones

Calcium supplements are not a treatment for kidney stones. No trial has shown they prevent stones, and in the Women's Health Initiative trial of 36,282 postmenopausal women, those given 1,000 mg of calcium with 400 IU of vitamin D a day for an average of 7 years reported 17% more stones than those on placebo (HR 1.17, 95% CI 1.02 to 1.34) (Wallace 2011). Reviews of mostly shorter trials in people with osteoporosis found no significant increase (Candelas 2012; NIH ODS 2026).

Calcium in food is a different story. In three cohorts of more than 230,000 men and women, people who ate the most calcium had a 27-35% lower risk of stones than those who ate the least (Curhan 1993; Curhan 1997; Curhan 2004), and in men with recurrent calcium oxalate stones and high urine calcium, a normal-calcium diet with less salt and animal protein halved relapses compared with a low-calcium diet (Borghi 2002). So the practical answer is: don't cut dietary calcium, and if you need a supplement for your bones, take it with meals.

Most stones are calcium oxalate. Calcium and oxalate bind in the gut, so calcium eaten with food ties up dietary oxalate and less of it is absorbed and passed into the urine. Calcium taken between meals has little oxalate to bind, so it may raise urine calcium without that benefit (Bargagli 2021).

A crossover study tested this directly in 32 healthy young men on a controlled diet. Taking 1 g of calcium carbonate (about 400 mg of calcium) with each of three meals for a week lowered urinary oxalate (0.17 to 0.13 mmol/day, P = 0.01) and did not significantly change the calcium oxalate activity product, a measure of stone-forming potential (0.54 vs 0.57, P = 0.54). Taking all 3 g in one dose at bedtime did not lower oxalate and raised the activity product (0.47 to 0.72, P < 0.01). Urine calcium rose with both schedules. The bedtime schedule was also one large dose, so timing and dose size are mixed together (Domrongkitchaiporn 2004; NIH ODS 2026).

These are 1- to 2-week urine studies, not stone outcomes. In 18 postmenopausal women without stones, calcium citrate (400 mg of calcium twice daily) raised urine calcium and citrate but lowered urine oxalate, and calcium oxalate saturation did not change (Sakhaee 2004), which says little about stones over years. No trial has compared calcium citrate with calcium carbonate on actual stones.

People who form stones also handle calcium differently. In 5,452 older women who had calcium absorption tested, those with a past stone absorbed a larger share of their calcium at every intake level, and each 10% rise in absorption was linked to 24% higher odds of having had a stone (Sorensen 2012, Study of Osteoporotic Fractures). A dose that is harmless for one person may add more calcium to the urine of another.

There is no stone-prevention dose of calcium. The goal is a normal total intake: 1,000 mg a day for adults aged 19-50 and men aged 51-70, and 1,200 mg for women over 50 and everyone over 70; children and teens aged 9-18 need 1,300 mg (NIH ODS 2026). The upper limits, 2,500 mg a day for adults aged 19-50 and 2,000 mg after 50, were set because of the kidney stone excess in the Women's Health Initiative (NIH ODS 2026). The diet that halved relapses in men with recurrent stones, which also cut salt and animal protein, contained 30 mmol of calcium a day, roughly 1,200 mg, against 10 mmol in the low-calcium diet (Borghi 2002).

If you need a supplement, take it with meals: a 2014 review of the stone evidence advises stone formers to take calcium supplements with a meal and to have their stone disease monitored (Sorensen 2014). Calcium carbonate is 40% calcium and is best absorbed with food; calcium citrate is 21% calcium and depends less on stomach acid, so it can be taken without food, although for stone formers taking it with a meal keeps the oxalate-binding benefit. Absorption is highest at 500 mg or less per dose, and labels list elemental calcium (NIH ODS 2026).

The Women's Health Initiative gave 36,282 women aged 50-79 either 500 mg of calcium (as calcium carbonate) with 200 IU vitamin D3 twice daily or placebo for an average of 7.0 years. Stones were reported by 449 women on supplements and 381 on placebo (HR 1.17, 95% CI 1.02 to 1.34), with no subgroup at clearly higher or lower risk, and results held when non-adherent women were censored (Wallace 2011; Jackson 2006). Because calcium and vitamin D were given together, the trial can't say which caused the excess; a meta-analysis of vitamin D trials found more high urine calcium (RR 1.64) but not more stones (RR 0.66, 95% CI 0.41 to 1.09) (Malihi 2016).

Other reviews are more reassuring but weaker. Across 10 studies in more than 8,000 people with osteoporosis taking 120 to 1,500 mg calcium for 3 days to 3 years, supplements did not significantly increase stones or renal colic (Candelas 2012). A single-author review concluded that most studies show no increase in stone risk with high calcium intake from diet or supplements (Heaney 2008). Neither tested whether calcium prevents stones.

Food calcium is linked to fewer stones in most cohorts. Men with the highest intake had a 34% lower risk after adjustment (RR 0.66, 95% CI 0.49 to 0.90; 45,619 men) (Curhan 1993), women aged 34-59 at entry a 35% lower risk (RR 0.65; 91,731 women) (Curhan 1997) and younger women a 27% lower risk (RR 0.73; 96,245 women) (Curhan 2004). The link held for both dairy and nondairy calcium (Taylor 2013) and in 78,293 women in the WHI Observational Study (Sorensen 2012, WHI Observational Study). In men it was seen only under age 60 (Taylor 2004).

Supplements look different. In that cohort of women aged 34-59 at entry, supplement users had a 20% higher risk (RR 1.20, 95% CI 1.02 to 1.41), and 67% of them took calcium without a meal or with a low-oxalate meal (Curhan 1997). In younger women and in men, supplemental calcium was not associated with risk (Curhan 2004; Taylor 2004). These are observational studies, so other features of calcium-rich diets may explain part of the benefit.

In 120 men with recurrent calcium oxalate stones and high urine calcium, a diet with normal calcium but less animal protein and salt led to relapses in 12 of 60 men over 5 years, against 23 of 60 on a low-calcium diet (RR 0.49, 95% CI 0.24 to 0.98, P = 0.04). Urine oxalate fell on the normal-calcium diet and rose on the low-calcium one (Borghi 2002). No trial has tested dietary calcium on its own (Fink 2009), and a 2026 review rated a diet with normal to high calcium, low protein and low sodium as possibly reducing recurrence, with low strength of evidence (Asher 2026).

The best-proven steps are elsewhere. More fluid halved recurrence after a first calcium stone (RR 0.45), and in people with several stones, thiazides (RR 0.52), citrates (RR 0.25) and allopurinol (RR 0.59) cut it further (Fink 2013). The American College of Physicians recommends drinking enough to produce at least 2 litres of urine a day, then a thiazide, citrate or allopurinol if stones keep forming (Qaseem 2014). For comparison, see magnesium for kidney stones.

One group uses calcium deliberately: people with enteric hyperoxaluria, where fat malabsorption from bowel disease or bariatric surgery lets too much oxalate be absorbed. Calcium salts taken to bind oxalate in the gut are one of the few treatments, but evidence that they reduce stone events or kidney damage is lacking (Witting 2021). In stone formers with high urine oxalate more generally (not specifically enteric), a retrospective study of 22 patients found adding calcium citrate at meals lowered urine oxalate from 60 to 46 mg/day, similar to diet changes alone (56 to 43 mg/day), without raising urine calcium (Penniston 2009). If this applies to you, it is managed with your gastroenterologist or kidney specialist; see Crohn's disease.

Missing: a randomised trial of calcium supplements taken with meals versus none, in people who form stones, measuring new stones; and trials separating calcium from vitamin D. Almost all the supplement data come from postmenopausal women.

Stone risk is the main concern, and it is why the upper intake limits were set (NIH ODS 2026); the trial and cohort figures are in the evidence section above. Vitamin D taken long term raises the chance of high blood calcium (RR 1.54) and high urine calcium (RR 1.64) (Malihi 2016), and reviewers suggest vitamin D may worsen stone risk in people prone to high urine calcium (Bargagli 2021).

High blood calcium is rare in healthy people and usually comes from cancer, primary hyperparathyroidism or other conditions (NIH ODS 2026), so a stone former with high blood calcium needs that cause found before any supplement; ask whether your blood calcium has been checked. On a thiazide, markedly high blood calcium may be a sign of hidden hyperparathyroidism (FDA hydrochlorothiazide label). High blood and urine calcium can also harm kidney function (NIH ODS 2026), so if you have chronic kidney disease, calcium intake should be set with your kidney specialist. If you take calcium for osteoporosis and have had stones, don't stop on your own; ask whether to keep it, switch to food sources or change how you take it.

Thiazide diuretics, often prescribed to prevent stones, reduce calcium loss in the urine and can slightly raise blood calcium (FDA hydrochlorothiazide label), so adding supplements should be agreed with your prescriber. Long-term lithium can cause high blood calcium, and calcium supplements could add to that risk (NIH ODS 2026). Calcium also reduces absorption of several medicines: keep calcium carbonate 4 hours from levothyroxine, take quinolone antibiotics 2 hours before or after calcium, and take dolutegravir 2 hours before or 6 hours after it (NIH ODS 2026). Calcium interferes with alendronate, so take the tablet first and wait at least half an hour before any other oral medicine; the same label tells patients to take supplemental calcium if their diet falls short (FDA alendronate label).